OMI Welcomes Steve Wiggins to Strengthen Healthcare Innovations as Board Observer

Outcomes Matter Innovations Welcomes Steve Wiggins as Board Observer

Jersey City, N.J. – June 30, 2026 – Outcomes Matter Innovations (OMI), a pioneering company in healthcare technology focusing on value-based specialty care, has just announced an exciting addition to its leadership team. Steve Wiggins, a recognized figure in the healthcare sector as an entrepreneur and investor, will join OMI as a Board Observer.

Wiggins brings with him over three decades of significant experience in founding, scaling, and advising some of the most impactful healthcare organizations in the United States. His extensive background includes the creation of notable firms such as Oxford Health Plans, HealthMarket, and Remedy Partners, along with recent ventures like Oxbridge Health and Opennetworks.org. He has even served in advisory roles to two U.S. Presidents, providing insights into key healthcare issues facing the nation.

As a Board Observer, Wiggins will offer strategic insights that are crucial for OMI as it continues to broaden its presence within both provider and payer organizations. His keen understanding of high-growth health companies and navigation of complex payment and delivery systems aligns closely with OMI’s mission to achieve real-time clinical and financial alignment for specialty care solutions.

Dr. Andrew Pecora, CEO of OMI, expressed enthusiasm about Wiggins’ involvement, stating, "Steve is a nationally recognized innovator in healthcare. His leadership and vision will be invaluable as we further develop our technology and partnerships. We are thrilled to have him on our team at this key stage of our growth."

Wiggins has a rich background encompassing health insurance, value-based care, specialty care management, and healthcare technology — domains that resonate with OMI’s focus on enhancing patient outcomes and alleviating unnecessary variations, particularly in high-cost clinical areas like oncology, ophthalmology, and chronic disease management.

Wiggins spoke to the importance of OMI’s objectives, stating, "OMI is addressing one of healthcare’s most pressing challenges: the delivery of predictable, evidence-aligned, and affordable specialty care at scale. I look forward to supporting the team in increasing transparency, accountability, and performance for providers and payors nationwide."

OMI leverages a sophisticated platform that facilitates real-time decision-making related to clinical pathways, cost modeling, and performance analytics, all designed to empower organizations in value-based care initiatives while simultaneously enhancing patient care outcomes. The company is steadily growing its partnerships across health systems, specialty practices, and national payors.

About Outcomes Matter Innovations

Established in 2018, Outcomes Matter Innovations, LLC (OMI) is a New Jersey-based firm committed to providing specialty physicians with real-time decision-support technology at critical points of care. Their innovative reimbursement models are designed to enhance high-value specialty care programs aimed at maintaining or improving clinical quality outcomes while significantly reducing costs.

OMI is on an ambitious path to national expansion, collaborating with various specialty physicians to develop clinical treatment pathways that integrate seamlessly into their technology, primarily targeting conditions with high total costs and significant variability in expenses, all in pursuit of better clinical outcomes and lowered care costs.